Skip to content

22q11 2 Deletion Syndrome Cn294181

Published: July 22, 2026Updated: August 20, 2026

A genetic condition where a small piece of chromosome 22 is missing. It can affect the heart, immune system, and development. Treatment involves managing symptoms across multiple specialties.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Congenital heart defects

Structural heart abnormalities including tetralogy of Fallot, ventricular septal defects, and truncus arteriosus.

Immediately; requires cardiac evaluation and possible surgical intervention in infancy.

!

Hypocalcemia

Low blood calcium levels due to parathyroid gland dysfunction, causing muscle cramps, tingling, and seizures.

Seek emergency care if experiencing seizures, severe muscle spasms, or difficulty breathing.

Distinctive facial features

(constitutional)

Characteristic facial appearance including wide-set eyes, small ears, nasal anomalies, and thin lips.

Frequency: 80-90% of patients

Recurrent infections

(immunologic)

Increased susceptibility to viral, bacterial, and fungal infections due to thymic hypoplasia and immune deficiency.

Frequency: 75-80% of patients

Cleft palate

(gastrointestinal)

Opening in the roof of the mouth that can affect feeding and speech development.

Frequency: 30-40% of patients

Developmental delays

(neurologic)

Delayed motor skills, speech, and language development; learning disabilities are common.

Frequency: 70-80% of patients

Renal anomalies

(genitourinary)

Kidney abnormalities including absent, small, or malformed kidneys; increased risk of urinary tract infections.

Frequency: 30-35% of patients

Psychiatric symptoms

(psychiatric)

Increased risk of schizophrenia, anxiety disorders, and depression, often emerging in adolescence or adulthood.

Frequency: 25-30% of patients

Thrombocytopenia

(hematologic)

Low platelet count causing easy bruising, bleeding gums, and prolonged bleeding from cuts.

Frequency: 10-15% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive lifelong surveillance program

Regular monitoring for multi-system manifestations including cardiac, immunological, endocrine, and neuropsychiatric features of 22q11.2 deletion syndrome. Annual comprehensive evaluations recommended.

monitoring
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Palatal reconstruction and ENT intervention

Surgical repair of cleft palate and management of velopharyngeal insufficiency to improve speech and feeding function. ENT evaluation for middle ear disease and hearing loss is essential.

surgical

Additional treatment options

Neuropsychiatric care and cognitive support

Integrated mental health care addressing anxiety disorders, depression, psychotic symptoms, and cognitive challenges. Combines medication management with psychotherapy and educational/vocational support.

psychological

Nutritional and metabolic support

Dietary management addressing feeding difficulties, failure to thrive in infancy, and metabolic concerns including hypocalcemia. May include specialized formulas, feeding therapy, and supplementation.

complementary

Motor development and physical rehabilitation

Therapeutic interventions addressing hypotonia, motor coordination difficulties, and joint hypermobility. Focuses on strength building, balance training, and functional independence.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 22q11 2 Deletion Syndrome Cn294181?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

McDonald-McGinn DM, Sullivan KE, Bassett AS, et al. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome). Nat Rev Dis Primers. 2021.

review2021View source →
2

American Academy of Pediatrics Council on Children with Disabilities. Clinical practice guidelines for the evaluation and management of infants with 22q11.2 deletion syndrome. Pediatrics. 2023.

guideline2023View source →
3

GeneReviews: 22q11.2 Deletion Syndrome. University of Washington, Seattle. Updated 2024.

textbook2024View source →
4

Fung WLA, Butcher NJ, Costain G, et al. Practical guidelines for managing adults with 22q11.2 deletion syndrome. Am J Med Genet A. 2015;167A(8):1753-1765.

review2015View source →
5

Vergaelen E, De Smedt B, Van De Walle P, et al. A prospective study on the cognitive and behavioral phenotype of 22q11.2 deletion syndrome in children and adolescents. J Clin Psychiatry. 2020.

clinical_trial2020View source →
6

American College of Medical Genetics and Genomics. Clinical genetics testing for 22q11.2 deletion syndrome: ACMG practice resource. Genet Med. 2022.

position_statement2022View source →
7

Bassett AS, McDonald-McGinn DM, Devriendt K, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr. 2011;159(2):332-339.e1.

consensus2011View source →
8

Boot E, Butcher NJ, van Duin E, et al. Psychiatric disorders and educational outcomes in 22q11.2 deletion syndrome. Schizophr Bull. 2023;49(2):298-309.

review2023View source →
9

International Society for Chromosome 22q11.2 Deletion Syndrome. Consensus statement on the management of congenital heart disease in 22q11.2 deletion syndrome. 2020.

Medication Comparisons

Compare medications used to treat 22q11 2 Deletion Syndrome Cn294181. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy